CSPC Pharmaceutical Group (XTER:CVG) EPS (Basic): €0.03 (TTM As of Dec. 2025)


XTER:CVG CSPC Pharmaceutical Group Ltd XTER:CVG
88 GF Score
Price €0.40
GF Value €0.40
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group EPS (Basic)?

CSPC Pharmaceutical Group XTER:CVG 88 EPS (Basic) is €0.03 as of Dec. 2025. GuruFocus rates XTER:CVG with a GF Score™ of 88/100 and a GF Value™ of €0.40. The stock has 4 warning signs investors should review.

CSPC Pharmaceutical Group's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.

CSPC Pharmaceutical Group's EPS (Diluted) for the three months ended in Dec. 2025 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03.

CSPC Pharmaceutical Group's EPS without NRI for the three months ended in Dec. 2025 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.03.

During the past 12 months, CSPC Pharmaceutical Group's average EPS without NRIGrowth Rate was -99.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -14.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 57.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 49.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average EPS without NRI Growth Rate was 392.20% per year. The lowest was -60.80% per year. And the median was 24.80% per year.

CSPC Pharmaceutical Group  (XTER:CVG) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CSPC Pharmaceutical Group EPS (Basic) Related Terms

CSPC Pharmaceutical Group EPS (Basic) Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group EPS (Basic) Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.07 0.06 0.05 0.04

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.00 0.01
XTER:CVG
88GF Score
CSPC Pharmaceutical Group Ltd XTER:CVG
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CSPC Pharmaceutical Group's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(470.712-0)/11423.692
=0.04

CSPC Pharmaceutical Group's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(44.951-0)/11423.692
=0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.03 mean?
CSPC Pharmaceutical Group (XTER:CVG) has a EPS (Basic) of €0.03 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's EPS (Basic) too high?
CSPC Pharmaceutical Group's current EPS (Basic) is €0.03. Overall, CSPC Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's EPS (Basic) compare to LLY and JNJ?
CSPC Pharmaceutical Group's EPS (Basic) of €0.03 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current EPS (Basic) is €0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (XTER:CVG) has a current EPS (Basic) of €0.03. The stock's GF Value™ is €0.40, compared to a current price of €0.40 — trading right at its estimated fair value. The current EPS (Basic) is €0.03. CSPC Pharmaceutical Group's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For CSPC Pharmaceutical Group (XTER:CVG), the current EPS (Basic) is €0.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (XTER:CVG) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be undervalued. The current stock price of €0.40 is trading 0% below its estimated GF Value™ of €0.40.

Key valuation signals for XTER:CVG:

  • EPS (Basic): €0.03
  • GF Value™: €0.40 vs. price of €0.40 (0% below fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the XTER:CVG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
88GF Score

Get the complete analysis for XTER:CVG

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.40
Price
€0.40
GF Value